GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Navco Pharmaceuticals NAV.V · CAD

N/A · TSX Venture · 🇨🇦 Canada

Compare

0.01

—

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CAD, from our data supplier.

FY2024

Net income

−C$1.7m

FY2021FY2024

Free cash flow

−C$253,300

FY2021FY2024

Shareholders' equity

−C$856,800

FY2021FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021
Operating income−C$1.6m−C$1.5m−C$100,092−C$79,542
Net income−C$1.7m−C$2.1m−C$93,680−C$74,082
Diluted earnings per share-0.03-0.07-0.02-0.02

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021
Total assetsC$75,200C$931,800C$112,171C$116,027
Cash and short-term investmentsC$7,400C$234,700——
Total liabilitiesC$932,000C$844,400C$108,699C$18,875
DebtC$64,300C$112,600——
Shareholders' equity−C$856,800C$87,500C$3,472C$97,152
Shares outstanding52m30m5m5m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021
Cash from operations−C$253,300−C$1.8m−C$10,268−C$80,710
Free cash flow−C$253,300−C$1.8m−C$10,268−C$80,710

Latest quarters

By quarter end

Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023
Operating income−C$8,700−C$15,700−C$8,500−C$765,800−C$169,900−C$394,700−C$270,200−C$772,800
Net income−C$11,200−C$18,100−C$10,400−C$876,600−C$177,500−C$396,500−C$272,000C$1.3m
Diluted earnings per share-0.00-0.00-0.00-0.02-0.00-0.01-0.010.01
Total assetsC$6,700C$19,200C$56,300C$75,200C$951,300C$1.0mC$606,900—
Cash and short-term investmentsC$6,700C$19,200C$1,400C$7,400C$11,200C$21,500C$79,600—
DebtC$76,500C$76,500C$54,500C$54,500C$108,300C$91,600C$95,000—
Shareholders' equity−C$896,500−C$885,300−C$867,200−C$856,800C$19,900C$197,400−C$184,500—

Growth per year

Compound annual rate

3 years5 years10 years
Operating income172.0%——
Net income185.4%——

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.